Development of a safe and effective treatment for neuropathology in MPS IIIA.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/565074

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

MPS IIIA is an inherited disorder that results in progressive brain disease in affected children. The disorder cannot be treated at present because it has not been possible to find an effective way to deliver treatment to the brain. This project seeks to evaluate a method to overcome this problem. Findings in this project can be applied to other, similar disorders that affect the brain.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2011

Funding Scheme: NHMRC Project Grants

Funding Amount: $665,320.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Genetics

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Sanfilippo syndrome | animal model | enzyme therapy | incurable, progressive, neurological disease | inherited metabolic disorders | lysosomal storage disorder | targeted therapy | treatment of central nervous system pathology | treatment of lysosomal storage disorders

Related Links